Atherosclerosis and cancer: Common pathways on the vascular endothelium

M. Morganti, A. Carpi, A. Nicolini, I. Gorini, B. Glaviano, M. Fini, G. Giavaresi, Ch Mittermayer, R. Giardino

Research output: Contribution to journalArticlepeer-review


This article reviews experimental and clinical data on atherosclerosis and cancer showing common pathogenic mechanisms. It is suggested that common pathways follow dysfunction of the vascular endothelium. The activation of the haemostatic system and the overexpression of cytokines and adhesion molecules by the endothelial cells represent important features of this dysfunction. These mechanisms can be responsible for progression of both diseases and explain the higher incidence of thromboembolic events in cancer patients, the occurrence of similar laboratory findings and the effect of many drugs on the course of the two diseases. Our article confirms that atherosclerosis and cancer share common mechanisms, and we hope it will stimulate further clinical trials on the use of drugs active on the haemostatic system in cancer patients.

Original languageEnglish
Pages (from-to)317-324
Number of pages8
JournalBiomedicine and Pharmacotherapy
Issue number7
Publication statusPublished - Sep 2002


  • Adhesion molecules
  • Atherosclerosis
  • Cancer haemostasis
  • Cytokines

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Atherosclerosis and cancer: Common pathways on the vascular endothelium'. Together they form a unique fingerprint.

Cite this